Skip to main navigation
Skip to search
Skip to main content
Sort by
Pharmacology, Toxicology and Pharmaceutical Science
Malignant Neoplasm
89%
Diseases
77%
Neoplasm
71%
Liver Cell Carcinoma
58%
Cohort Study
57%
Infection
56%
Bloodstream Infection
34%
Lung Cancer
33%
Epidermal Growth Factor Receptor
31%
Prevalence
28%
Inflammation
27%
Hepatitis B Virus
27%
Diabetes Mellitus
27%
Overall Survival
25%
Chemotherapy
24%
Non Small Cell Lung Cancer
24%
Carcinogenesis
22%
Non Insulin Dependent Diabetes Mellitus
21%
Antiinfective Agent
20%
Breast Cancer
19%
Biological Marker
19%
Helicobacter pylori
19%
Cardiovascular Disease
19%
Tumor Growth
19%
Cytokine
19%
Cerebrovascular Accident
19%
Protein P53
19%
Combination Therapy
18%
Colorectal Carcinoma
18%
Adverse Event
18%
Reactive Oxygen Metabolite
18%
Bladder Cancer
17%
Receptor
17%
Chronic Hepatitis B
17%
Comorbidity
17%
Hemodialysis
17%
Brain Ischemia
17%
Cisplatin
16%
Hepatitis B
15%
Nanoparticle
15%
Tumor Necrosis Factor
15%
Messenger RNA
14%
Drug Resistance
14%
Progression Free Survival
14%
Cytotoxicity
14%
Chronic Kidney Failure
13%
Chronic Hepatitis C
13%
Life Expectancy
13%
Placebo
13%
Mortality Rate
13%
Lipopolysaccharide
13%
End Stage Renal Disease
13%
Calcium Ion
13%
Nitric Oxide
12%
Hepatitis C Virus
12%
Virus Infection
12%
HIV
12%
Escherichia coli
12%
Phthalic Acid
12%
microRNA
12%
Integrin
12%
Congestive Heart Failure
11%
Alzheimer's Disease
11%
Survival Rate
11%
Squamous Cell Carcinoma
11%
Interleukin 6
11%
Retrospective Study
11%
Infectious Agent
11%
Antimicrobial Resistance
11%
Recurrent Disease
11%
Abdominal Cancer
11%
Case-Control Study
11%
Prostate Cancer
11%
Dengue
11%
Lung Adenocarcinoma
10%
All Cause Mortality
10%
Liver Injury
10%
Phosphotransferase
10%
Sepsis
10%
Klebsiella pneumoniae
10%
Liver Cirrhosis
10%
Hepatitis C
9%
Statin (Protein)
9%
Wound Healing
9%
Antibiotics
9%
Clinical Trial
9%
Nonalcoholic Fatty Liver
9%
Liver Cancer
9%
Penicillinase
9%
IC50
9%
Parkinson's Disease
9%
Dengue Virus
9%
Mouse Model
9%
Observational Study
9%
Paclitaxel
9%
Enterovirus A71
9%
Fibrosis
9%
Antioxidant
9%
Thrombomodulin
9%
Alanine Aminotransferase
9%
Medicine and Dentistry
Diseases
58%
Cohort Analysis
51%
Neoplasm
49%
Hepatocellular Carcinoma
37%
Infection
35%
Hazard Ratio
34%
Malignant Neoplasm
33%
Odds Ratio
30%
Diabetes
28%
Overall Survival
24%
Prevalence
23%
Apoplexy
23%
Epidermolysis bullosa
21%
Epidermolysis Bullosa Dystrophica
20%
Meta-Analysis
20%
Diabetes Mellitus
20%
Metastatic Carcinoma
19%
Quality of Life
19%
In Vitro
19%
Bloodstream Infection
18%
Cancer
18%
Lung Cancer
17%
Systematic Review
17%
Health Care Cost
16%
Breast Cancer
16%
Cancer Cell
16%
Epidermal Growth Factor Receptor
16%
Programmed Cell Death
15%
Maturity Onset Diabetes of the Young
15%
Emergency Department
15%
Non Small Cell Lung Cancer
15%
Biological Marker
15%
Logistic Regression Analysis
14%
Chronic Kidney Disease
14%
Comorbidity
14%
Transitional Cell Carcinoma
14%
COVID-19
14%
Mortality Rate
14%
End Stage Renal Disease
13%
Helicobacter pylori
13%
Hemodialysis
13%
Proportional Hazards Model
13%
Life Expectancy
13%
Computer Assisted Tomography
13%
Recurrent Disease
13%
Lifespan
12%
Retrospective Cohort Study
12%
Resuscitation
12%
Cardiovascular System
11%
Pediatrics
11%
Colorectal Carcinoma
11%
Cardiovascular Disease
11%
Retrospective Study
11%
Prognostic Factor
11%
Squamous Cell Carcinoma
11%
Human immunodeficiency virus
10%
Hepatitis B Virus
10%
Radiation Therapy
10%
Adverse Event
10%
Magnetic Resonance Imaging
10%
Progression Free Survival
10%
Cross Sectional Study
10%
Combination Therapy
10%
Tumor Progression
10%
Multivariate Analysis
9%
Chronic Hepatitis C
9%
Fibroblast
9%
Gestational Age
9%
Congestive Heart Failure
9%
Cardiology
9%
Randomized Controlled Trial
9%
Biopsy Technique
9%
Survival Rate
9%
Oral Cancer
8%
Bleeding
8%
Keratinocyte
8%
Endometriosis
8%
Ovarian Cancer
8%
Suture
8%
Brain Ischemia
8%
Cell Signaling Pathway
8%
Wound Healing
8%
Intensive Care Unit
8%
Clinical Trial
8%
Carcinogenesis
8%
Body Mass Index
8%
Nasopharynx Carcinoma
8%
Cerebral Hemorrhage
8%
Antiinfective Agent
8%
Pathogen
8%
Lung
8%
Medicine
7%
Autophagy
7%
Chronic Obstructive Pulmonary Disease
7%
Cell Migration
7%
Hepatitis C Virus
7%
Patient with Diabetes
7%
Arterial Stiffness
7%
Dermatosis
7%
Echography
7%
Keyphrases
Taiwan
100%
Confidence Interval
27%
Taiwanese
19%
Epidermolysis Bullosa
17%
National Cohort Study
14%
Hazard Ratio
13%
Odds Ratio
11%
Population-based Cohort Study
10%
Hepatocellular Carcinoma
8%
Risk Factors
8%
Meta-analysis
8%
Diabetes
7%
Bacteremia
7%
Lung Cancer
7%
IL-20
7%
Southern Taiwan
7%
Type 2 Diabetes Mellitus (T2DM)
6%
Overall Survival
6%
Bipolar Disorder
6%
Apoptosis
6%
Quality of Life
6%
Integrin
6%
High Risk
6%
Polymorphism
5%
Chronic Hepatitis C
5%
Hepatitis C Virus
5%
Type 1 Diabetes Mellitus (T1DM)
5%
Adjusted Odds Ratio
5%
Epidermal Growth Factor Receptor
5%
Autophagy
5%
Emergency Department
5%
Comorbidity
5%
Apologizing
5%
Systematic Meta-analysis
5%
Helicobacter Pylori (H. pylori)
5%
Hospitalization
5%
Adjusted Hazard Ratio
5%
Rheumatoid Arthritis
5%
Hepatitis C
5%
Cancer Cells
5%
Enterovirus 71 (EV71)
5%
Induced Apoptosis
5%